Lexpos News

Community Pharmacy England met in London for a full Committee Meeting on 13th and 14th September 2023. Committee Members spent time considering a response to the Government on the Primary Care Access Recovery Plan negotiations and laying the groundwork for the next Community Pharmacy Contractual Framework (CPCF) negotiations, informed by sector polling. The packed two-day [...]

The post Committee strategy discussions informed by pharmacy owners at September Meeting appeared first on Community Pharmacy England.

Following the recommendations made by the Independent Medicines and Medical Devices Safety Review and the outcome of a recent public consultation on Original pack dispensing and supply of medicines containing sodium valproate, changes to Human Medicines Regulations 2023 come into effect on the 11th October that mandate full pack dispensing of all licensed medicines containing valproate (see exemption [...]

The post All valproate containing products reclassified as special containers from October 2023 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Azelaic acid (Skinoren®) 20% cream. MSN/2023/090 Tier 2 – medium impact Date of issue 27th September 2023 Azelaic acid (Skinoren®) 20% cream is out of stock until early November 2023. Azelaic acid (Finacea®) 15% gel remains available but cannot support an [...]

The post Medicine Supply Notification: Azelaic acid (Skinoren®) 20% cream appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan®)100mg capsules. MSN/2023/091 Tier 2 – medium impact Date of issue 27th September 2023 Disopyramide (Rythmodan®)100mg capsules are out of stock until late October 2023. Disopyramide (Rythmodan®) 250mg prolonged release tablets are out of stock until mid-December 2023 but parallel [...]

The post Medicine Supply Notification: Disopyramide (Rythmodan®)100mg capsules appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Drug alert number:EL (23)A/37 Date issued: 27 September 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Company name: Max Remedies Ltd [...]

The post Class 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) appeared first on Community Pharmacy England.